Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Oct 21;14(4):310-321.
doi: 10.3390/hematolrep14040045.

Acute Promyelocytic Leukemia in a Woman with Thalassemia Intermedia: Case Report and Review of Literature on Hematological Malignancies in β-Thalassemia Patients

Affiliations
Case Reports

Acute Promyelocytic Leukemia in a Woman with Thalassemia Intermedia: Case Report and Review of Literature on Hematological Malignancies in β-Thalassemia Patients

Claudio Pellegrino et al. Hematol Rep. .

Abstract

Patients affected by transfusion-dependent β-thalassemia are prone to developing several clinical complications, mostly related to the iron overload. We report the case of a patient affected by transfusion-dependent β-thalassemia (TDT) developing acute promyelocytic leukemia (APL). In our case, the therapeutic management was significantly complicated not only by myocardial dysfunction, but also by the occurrence of the differentiation syndrome following all-trans retinoic acid (ATRA) administration. We carried out a careful revision of the current literature on the occurrence of hematological malignancies in β-thalassemia patients to investigate the major complications so far described. APL occurrence in β-thalassemia patients has been very rarely reported, and our experience suggests that TDT patients suffering pre-existing comorbidities may develop a potentially fatal complication during ATRA therapy.

Keywords: ATRA differentiation syndrome; acute promyelocytic leukemia; hematological malignancies; retinoic acid; β-thalassemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Upper picture: peripheral blood smear, showing anisopoikilocytosis, microcytic hypochromic red cells, and numerous target cells. In the center, a leukemic promyelocyte (black arrow). (B) Lower picture: bone marrow blood smear, showing promyelocytes (black arrows) and marked dyserythropoiesis (red arrow).
Figure 2
Figure 2
Gantt graph displaying patient’s clinical course during the treatment of acute promyelocytic leukemia (Office Timeline.Version 6.00.06, 2021 Office Timeline Inc., Bellevue WA 98004, USA). AF: atrial fibrillation; ATRA: all trans-retinoid acid; VM: Ventimask.
Figure 3
Figure 3
Chest X-ray and TC scan documenting bilateral pulmonary infiltrates and pleural effusion during ATRA differentiation syndrome (Carestream Vue Motion Version 12.1.5.9529 © Carestream Health, Inc., Rochester, NY, USA, 2021). D: RIGHT side.

Similar articles

Cited by

References

    1. Taher A.T., Cappellini M.D. How I manage medical complications of b-thalassemia in adults. [(accessed on 18 May 2022)];Blood. 2018 132:1781–1791. doi: 10.1182/blood-2018-06-818187. Available online: http://ashpublications.org/blood/article-pdf/132/17/1781/1468099/blood81.... - DOI - PubMed
    1. Mufti G.J., Bennett J.M., Goasguen J., Bain B.J., Baumann I., Brunning R., Cazzola M., Fenaux P., Germing U., Hellström-Lindberg E. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. [(accessed on 18 May 2022)];Haematologica. 2008 93:1712–1717. doi: 10.3324/haematol.13405. Available online: https://haematologica.org/article/view/5076. - DOI - PubMed
    1. Sanz M.A., Fenaux P., Tallman M.S., Estey E.H., Löwenberg B., Naoe T., Lengfelder E., Döhner H., Burnett A.K., Chen S.-J., et al. Management of acute promyelocytic leukemia: Updated recommendations from an expert panel of the European LeukemiaNet. [(accessed on 18 May 2022)];Blood. 2019 133:1630–1643. doi: 10.1182/blood-2019-01-894980. Available online: https://pubmed.ncbi.nlm.nih.gov/30803991/ - DOI - PMC - PubMed
    1. Lo-Coco F., Avvisati G., Vignetti M., Breccia M., Gallo E., Rambaldi A., Paoloni F., Fioritoni G., Ferrara F., Specchia G., et al. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: Results of the AIDA-2000 trial of the GIMEMA Group. Blood. 2010;116:3171–3179. doi: 10.1182/blood-2010-03-276196. - DOI - PubMed
    1. Balestrazzi P., Butturini A. Thalassemia and Hodgkin lymphoma. Blut. 1985;50:55. doi: 10.1007/BF00319772. - DOI - PubMed

Publication types

LinkOut - more resources